History of haemophilia

被引：8

作者：

Aledort, L. M. ^{[1
]}

机构：

[1] Mt Sinai Sch Med, New York, NY 10029 USA

来源：

HAEMOPHILIA | 2007年 / 13卷

关键词：

haemophilia; inhibitors; recombinant and human-derived factors; von Willebrand disease;

D O I：

10.1111/j.1365-2516.2007.01576.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Haemophilia, an ancient disease, now has sophisticated methods for diagnosis and treatment. The genetically missing factors can now be supplied by fractionation of human-derived (HD) plasma or with recombinant technology (r). Making therapeutic choices is complicated by past transfusion-transmitted diseases. HD and r products now have similar safety profiles. Several diseases have only HD products for treatment. These products remain important in our treatment armamentarium.

引用

页码：1 / 2

页数：2